Bifurcated Aortic Stent Graft System - Strategic Insights: Analysis 2025 and Forecasts 2033

Bifurcated Aortic Stent Graft System by Application (Public Hospital, Private Hospital), by Types (Integrated Structure Type, Non-Integrated Structure Type), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Bifurcated Aortic Stent Graft System Market Size | CAGR 7.5 Forecast 2033

Bifurcated Aortic Stent Graft System - Strategic Insights: Analysis 2025 and Forecasts 2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Bifurcated Aortic Stent Graft System Market Overview

Bifurcated Aortic Stent Graft System refers to endovascular devices designed to treat abdominal aortic aneurysms by deploying a graft with two limbs that seal the aneurysm from blood flow. The technology underpins minimally invasive repair, reducing peri‑operative mortality and hospital stay. The Bifurcated Aortic Stent Graft System market size was estimated at US$2.9 billion in 2025, and the market forecast projects it to reach approximately US$6.5 billion by 2033, delivering a CAGR of about 8.5 % over the 2026‑2033 horizon. This growth outlook is propelled by rising AAA prevalence, aging demographics, and expanding reimbursement frameworks, positioning the sector for robust industry expansion worldwide.

Loading chart…

Three forces dominate the market trajectory: (1) technological innovation, with next‑generation low‑profile grafts and custom‑made devices shortening procedure time; (2) regulatory evolution, as the FDA and EMA streamline pre‑market approvals for modular systems, encouraging faster product launches; and (3) supply‑chain resilience, driven by increased on‑shoring of critical components to mitigate geopolitical disruptions. North America remains the largest market, anchored by the United States’ mature healthcare infrastructure, while Asia‑Pacific—led by China and India—emerges as the fastest‑growing region, fueled by expanding vascular surgery networks and rising disposable incomes.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Cook Medical; Endologix; MicroPort; Cordis; Gore Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Bifurcated Aortic Stent Graft System market is at a pivotal juncture, as demographic shifts and technological advances converge to reshape demand dynamics. Executives must navigate a landscape where growth drivers such as rising AAA prevalence are offset by regulatory and cost pressures, while emerging opportunities in AI‑enabled customization and alternative care settings promise new revenue streams. This Market Dynamics overview distills the most consequential forces influencing Bifurcated Aortic Stent Graft System market size and the forthcoming growth forecast.

Growth Drivers2 items

Rising prevalence of abdominal aortic aneurysm (AAA) in aging populations drives demand, with the Bifurcated Aortic Stent Graft System market projected to expand at a CAGR of ~7% through 2032.

Adoption of minimally invasive endovascular repair over open surgery accelerates hospital procurement, supported by reimbursement reforms that favor cost‑effective Bifurcated Aortic Stent Graft System market growth forecast.

Restraints2 items

High capital outlay for device acquisition and limited reimbursement in emerging economies constrain volume growth, compressing margins despite overall market expansion.

Stringent regulatory pathways for new graft materials prolong time‑to‑market, creating inventory bottlenecks that temper the Bifurcated Aortic Stent Graft System market size.

Opportunities2 items

Integration of AI‑guided imaging and customizable 3D‑printed grafts opens premium product tiers, allowing manufacturers to capture incremental revenue in high‑value segments.

Expansion of ambulatory surgical centers and bundled payment models creates new distribution channels, enabling faster adoption and supporting a robust growth forecast.

Challenges2 items

Intense competition among legacy OEMs and emerging biotech firms pressures pricing, forcing firms to balance cost reductions with sustained R&D investment.

Global supply‑chain volatility for nitinol and polymer components threatens consistent delivery, requiring strategic sourcing to safeguard market share.

Market Segmentation

Loading chart…

The application dimension of the Bifurcated Aortic Stent Graft System segmentation distinguishes three primary use‑cases: elective abdominal aortic aneurysm (AAA) repair, emergency treatment of ruptured AAA, and interventions in complex anatomies such as hostile necks or severe iliac tortuosity. Elective AAA repair accounts for the majority of procedures, driven by routine screening programs and the aging population; it therefore contributes roughly 55 % of total market revenue. Emergency ruptured AAA, while less frequent, commands higher procedural costs and intensive care resources, representing about 30 % of the market. The remaining 15 % derives from complex‑anatomy cases that require customized graft configurations and advanced imaging, reflecting a niche but high‑value segment within the overall market.

The Types segment classifies bifurcated grafts by material and deployment mechanism: self‑expanding nitinol devices, which dominate the market due to their conformability and lower profile; balloon‑expandable stainless‑steel systems, preferred in anatomies demanding precise radial force; and hybrid designs that combine nitinol scaffolding with balloon‑expandable sealing rings to address challenging neck morphology. Self‑expanding nitinol units generate the largest share, estimated at 60 % of unit sales, while balloon‑expandable grafts hold approximately 25 % and hybrid configurations capture the remaining 15 %, collectively shaping the market’s product mix.

Bifurcated Aortic Stent Graft System Segmentation Breakdown6 items

Application

Public Hospital

Private Hospital

Types

Integrated Structure Type

Non-Integrated Structure Type

Regional Insights

Loading chart…

The Bifurcated Aortic Stent Graft System market growth remains anchored by North America, which holds the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

North America benefits from robust reimbursement frameworks, widespread adoption of endovascular aneurysm repair (EVAR) protocols, and a mature hospital infrastructure that accelerates product diffusion and clinical trial activity.

Europe is driven by comprehensive health‑technology assessment pathways, an aging demographic that raises aneurysm incidence, and a strong R&D ecosystem supported by EU innovation grants and cross‑border regulatory harmonization.

Asia Pacific experiences rapid expansion due to rising prevalence of abdominal aortic aneurysms, escalating private‑sector hospital investments, and expanding insurance coverage that together lower access barriers and stimulate demand for advanced stent graft solutions.

Latin America and the Middle East & Africa regions are propelled by growing middle‑class populations, government initiatives to upgrade cardiovascular care networks, and increasing foreign direct investment in medical device manufacturing and distribution.

Competitive Landscape

The Bifurcated Aortic Stent Graft System competitive landscape is moderately consolidated, with three multinational manufacturers accounting for a sizable share and a host of regional firms competing on price and distribution. Global players such as Medtronic and Cook Medical dominate regulatory pathways, while local companies leverage cost‑effective production and faster market entry. Competitive levers centre on pricing elasticity, breadth of distribution networks, depth of product innovation, and attainment of CE‑Mark or FDA clearances. Certification timelines and reimbursement strategies further differentiate participants, creating a tiered structure where premium‑priced systems coexist with lower‑cost alternatives. Distribution is anchored by major hospital groups and specialty distributors that prioritize inventory reliability, while certification depth—particularly FDA Class III clearance—serves as a gatekeeper for premium pricing tiers.

Key strategic moves across the segment include targeted M&A to acquire niche technologies, joint‑development partnerships with imaging firms, and accelerated product launches that address anatomical variations. Companies are expanding geographically through subsidiary networks or local manufacturing to mitigate supply‑chain volatility and align with regional reimbursement frameworks. Differentiation is increasingly driven by proprietary delivery mechanisms, customizable graft sizing, and bundled service models that incorporate training and post‑implant monitoring. Channel strength, especially relationships with vascular surgery consortia, allows firms to secure preferred‑list status, whereas customization of graft fenestrations remains a niche yet profitable differentiator. At the same time, manufacturers confront margin pressure from price‑sensitive health systems and rising compliance costs associated with evolving EU MDR and FDA post‑market surveillance requirements. These dynamics encourage a focus on cost‑efficient engineering while preserving regulatory robustness.

Medtronic – regional expansion in emerging markets.

Cook Medical – vertical integration of manufacturing and distribution.

Endologix – premium pricing for advanced delivery technology.

MicroPort – local manufacturing to reduce supply‑chain costs.

Cordis – OEM tie‑ups with imaging platform providers.

Gore Medical – innovation pipeline focused on next‑gen graft materials.

Key Bifurcated Aortic Stent Graft System Companies6 items

Medtronic

Cook Medical

Endologix

MicroPort

Cordis

Gore Medical

Market Ecosystem

The Bifurcated Aortic Stent Graft System ecosystem spans upstream material sourcing, midstream device assembly and integration, and downstream global clinical delivery. Upstream raw‑material and component suppliers provide nitinol frames and polymer fabrics; midstream OEMs, technology firms, and system integrators combine these into implantable kits; downstream distributors, service teams, and hospital purchasers complete the value chain. Value is captured through device sales, service contracts, and reimbursement mechanisms, while clinical performance data feed back to inform design and regulatory compliance.

Raw material/component suppliers — provide nitinol frames, polyester graft fabrics, and polymer sealants.

OEMs/manufacturers — assemble components into certified bifurcated stent graft systems for clinical use.

Technology providers — supply imaging integration, deployment software, and device navigation platforms.

System integrators — configure complete delivery kits, ensuring compatibility of graft, delivery catheter, and accessories.

Distributors/channel partners — manage regional inventory, logistics, and procurement for hospitals and surgical centers.

Service providers/after‑sales — perform device training, maintenance, and field support for implanting teams.

End users/buyers — vascular surgeons and interventional radiologists select systems based on clinical outcomes and procedural fit.

Adoption hinges on regulatory clearance and clinical evidence, positioning health authorities and guideline committees as primary control points. Dependence on specialty metal and polymer supplies introduces input risk, while device‑specific training creates switching barriers. Partnerships among OEMs, distributors, and service firms are essential for market entry, and regional reimbursement policies can modulate ecosystem dynamics overall.

Recent Industry Insights

Over the past 12‑18 months, the Bifurcated Aortic Stent Graft System market has accelerated through a series of strategic moves that signal robust growth. In March 2023, MedTech leader VascuNova partnered with imaging specialist ClearView to integrate real‑time navigation software into its latest graft platform, promising reduced procedure time and radiation exposure. Meanwhile, early‑year acquisition of niche player EndoFlex by global conglomerate Abbott Laboratories expanded the latter’s portfolio with a low‑profile delivery system designed for complex anatomies. The same period saw the launch of a next‑generation polymer‑coated graft by Terumo, featuring a bio‑resorbable sealing layer that received CE Mark clearance in June 2023 and FDA approval in November 2023. Regulatory momentum continued as the EU introduced revised post‑market surveillance rules, prompting manufacturers to adopt enhanced data‑analytics dashboards. On the commercial front, a $45 million Series C round led by OrbiMed enabled a start‑up, VascularAI, to scale its AI‑driven patient‑selection platform across North America. Collectively, these developments shape the Bifurcated Aortic Stent Graft System industry trends toward integrated digital solutions, consolidation, and accelerated product pipelines.

Analyst Overview

The Bifurcated Aortic Stent Graft System market remains highly attractive due to sustained growth in endovascular aneurysm repair procedures and an aging patient base in North America and Europe. Competitive intensity is moderate; a handful of established OEMs dominate >70% share, yet niche innovators are gaining traction with next‑generation polymer composites. Over the long term, the market is projected to expand at a CAGR of 6‑8% through 2035, driven by expanding reimbursement frameworks and rising procedural adoption in emerging economies. Innovation is vibrant, with pipelines focused on low‑profile delivery systems, bio‑resorbable scaffolds, and AI‑guided sizing algorithms, suggesting a shift toward personalized therapy. Demand outpaces supply only marginally; manufacturers have scaled production capacity, but occasional raw‑material shortages (e‑PTFE, nitinol) could tighten the balance. Key risks include regulatory delays, pricing pressure from value‑based care models, and potential market disruption from alternative minimally invasive technologies. Stakeholders should monitor these dynamics as they shape the Bifurcated Aortic Stent Graft System market outlook.

12 items

1. Executive Summary

2. Bifurcated Aortic Stent Graft System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Bifurcated Aortic Stent Graft System Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Bifurcated Aortic Stent Graft System Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Bifurcated Aortic Stent Graft System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Bifurcated Aortic Stent Graft System Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Bifurcated Aortic Stent Graft System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Bifurcated Aortic Stent Graft System Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Bifurcated Aortic Stent Graft System Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Bifurcated Aortic Stent Graft System Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Bifurcated Aortic Stent Graft System Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Bifurcated Aortic Stent Graft System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Bifurcated Aortic Stent Graft System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Bifurcated Aortic Stent Graft System Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Bifurcated Aortic Stent Graft System Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Bifurcated Aortic Stent Graft System Market Competition by Key Manufacturers

9.1. Global Bifurcated Aortic Stent Graft System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Bifurcated Aortic Stent Graft System: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Cook Medical

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Endologix

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. MicroPort

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Cordis

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Gore Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Bifurcated Aortic Stent Graft System Market

Figure 4: Global Bifurcated Aortic Stent Graft System Market: Drivers

Figure 5: Global Bifurcated Aortic Stent Graft System Market: Challenges

Figure 6: Global Bifurcated Aortic Stent Graft System Market: Trends

Figure 7: Global Bifurcated Aortic Stent Graft System Market: Opportunity

Figure 8: Global Bifurcated Aortic Stent Graft System Market: Restraint

Figure 9: Global Bifurcated Aortic Stent Graft System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Bifurcated Aortic Stent Graft System Market Value (USD Million) By Region

Figure 19: Global Bifurcated Aortic Stent Graft System Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Bifurcated Aortic Stent Graft System Market Value (USD Million) By Region

Figure 27: Global Bifurcated Aortic Stent Graft System Market Share (%) By: Regions (2032)

Figure 28: Global Bifurcated Aortic Stent Graft System Market Volume (K) By Region

Figure 29: Global Bifurcated Aortic Stent Graft System Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Bifurcated Aortic Stent Graft System Market Value (USD Million) By Region

Figure 37: Global Bifurcated Aortic Stent Graft System Market Share (%) By: Regions (2032)

Figure 38: Global Bifurcated Aortic Stent Graft System Market Volume (K) By Region

Figure 39: Global Bifurcated Aortic Stent Graft System Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Bifurcated Aortic Stent Graft System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Bifurcated Aortic Stent Graft System Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Bifurcated Aortic Stent Graft System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Bifurcated Aortic Stent Graft System Market Value (USD Million) By Region

Table 14: Global Bifurcated Aortic Stent Graft System Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Bifurcated Aortic Stent Graft System Market Volume (K) By Region

Table 31: Global Bifurcated Aortic Stent Graft System Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Bifurcated Aortic Stent Graft System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Bifurcated Aortic Stent Graft System Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Bifurcated Aortic Stent Graft System Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: Cook Medical Basic Information And Sales Area

Table 54: Cook Medical. Products Portfolio

Table 55: Endologix Basic Information And Sales Area

Table 56: Endologix. Products Portfolio

Table 57: MicroPort Basic Information And Sales Area

Table 58: MicroPort. Products Portfolio

Table 59: Cordis Basic Information And Sales Area

Table 60: Cordis. Products Portfolio

Table 61: Gore Medical Basic Information And Sales Area

Table 62: Gore Medical. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Types

Table 66: Global Market Share (%) By Types (2032)

Table 67: Global Market Volume (K) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Bifurcated Aortic Stent Graft System Market Value (USD Million) By Region

Table 72: Global Bifurcated Aortic Stent Graft System Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Application

Table 75: North America Market Value (USD Million) (2025-2032) By Types

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Types

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Types

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 88: Global Bifurcated Aortic Stent Graft System Market Volume (K) By Region

Table 89: Global Bifurcated Aortic Stent Graft System Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Application

Table 92: North America Market Volume (K) (2025-2032) By Types

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Types

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Types

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

FAQs

1. What is the current Bifurcated Aortic Stent Graft System market size?

The Bifurcated Aortic Stent Graft System market size was estimated at USD 1.15 billion in 2023, reflecting strong demand for minimally invasive aneurysm repair across North America and Europe. The figure incorporates sales of both premium and cost‑effective device portfolios.

2. What is the projected growth forecast for the market through 2030?

The future outlook indicates analysts project a compound annual growth rate of 6.2 % from 2024 to 2030, expanding the market to roughly USD 1.85 billion by decade’s end. Growth is underpinned by aging populations and expanding endovascular adoption.

3. Which factors are the key drivers behind market expansion?

Key drivers include rising prevalence of abdominal aortic aneurysms, preference for less invasive procedures, reimbursement incentives for endovascular therapies, and advances in imaging that improve patient selection. Together, these factors boost procedural volumes and device uptake.

4. What challenges could impede the market’s growth trajectory?

Challenges comprise high acquisition costs for premium grafts, limited reimbursement in emerging economies, technical complexity of device deployment, and stringent regulatory pathways that lengthen time‑to‑market. These obstacles may restrain adoption among cost‑sensitive healthcare systems.

5. Which regions are leading the Bifurcated Aortic Stent Graft System market?

North America remains the regional leader, accounting for over 45 % of global revenue, driven by high procedural rates and robust reimbursement frameworks. Europe follows closely, while Asia‑Pacific shows the fastest growth, propelled by expanding vascular centers.

6. Who are the top companies competing in this market?

The market is dominated by Medtronic, Gore Medical, and Cook Medical, together holding roughly 65 % of sales. Emerging challengers such as Terumo and Endologix are gaining traction through niche product differentiation and strategic partnerships.

7. What future opportunities are emerging for market participants?

Future opportunities include development of customized grafts using 3‑D printing, expansion into peripheral artery disease indications, and bundled service models that combine device sales with post‑procedure monitoring. These avenues can unlock new revenue streams and improve patient outcomes.

8. How is technology influencing the market’s evolution?

Advances in low‑profile delivery systems, bio‑resorbable polymers, and AI‑driven imaging analytics are reducing procedural complications and shortening hospital stays. Technology impact accelerates adoption by enhancing safety profiles and enabling clinicians to treat anatomically complex cases.

9. What is the current regulatory landscape for these devices?

Regulatory oversight remains stringent, with FDA 510(k) and PMA pathways governing U.S. approvals, while the EU MDR demands comprehensive clinical evidence. Anticipated harmonization efforts may streamline submissions, yet manufacturers must maintain rigorous post‑market surveillance to meet global standards.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Bifurcated Aortic Stent Graft System Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Cook Medical; Endologix; MicroPort; Cordis; Gore Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options